<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJOG</journal-id><journal-title-group><journal-title>Open Journal of Obstetrics and Gynecology</journal-title></journal-title-group><issn pub-type="epub">2160-8792</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojog.2024.145062</article-id><article-id pub-id-type="publisher-id">OJOG-133294</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Pregnancy Preferences in Females of Reproductive Age with Sickle Cell Disease at Laquintinie Hospital: A Cross-Sectional Analysis
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Eposse</surname><given-names>Ekoube Charlotte</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jeannette</surname><given-names>Disso Massako</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mangala</surname><given-names>Fulbert Nkwele</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mandeng</surname><given-names>Ma Linwa Edgar</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Puepi</surname><given-names>Djike Yolande</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Merlin</surname><given-names>Boten Bounyom</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Erero</surname><given-names>F. Njiengwe</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>&amp;#201;p&amp;#233;e</surname><given-names>Patricia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hassanatou</surname><given-names>Iyawa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dora</surname><given-names>Mbonjo Bitsie</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Emmanuel</surname><given-names>Heles Nsang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Soumaiyatou</surname><given-names>Abba</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ngo</surname><given-names>Linwa Esther Eleonore</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ndolo</surname><given-names>Kondo Astrid</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gr&amp;#226;ce</surname><given-names>Tocki Toutou</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Moustapha</surname><given-names>Bilkissou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Essome</surname><given-names>Henri</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Paediatric Unit, Douala Laquintinie Hospital, Douala, Cameroon</addr-line></aff><aff id="aff2"><addr-line>Faculty of Health Sciences, University of Bamenda, Bamenda, Cameroon</addr-line></aff><aff id="aff1"><addr-line>Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon</addr-line></aff><pub-date pub-type="epub"><day>08</day><month>05</month><year>2024</year></pub-date><volume>14</volume><issue>05</issue><fpage>744</fpage><lpage>757</lpage><history><date date-type="received"><day>8,</day>	<month>April</month>	<year>2024</year></date><date date-type="rev-recd"><day>20,</day>	<month>May</month>	<year>2024</year>	</date><date date-type="accepted"><day>23,</day>	<month>May</month>	<year>2024</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  &lt;b&gt;Introduction:&lt;/b&gt; Females with sickle cell disease (SCD), despite having a delayed pubertal development, are subject to many worries relating to their abilities to conceive, their capacity to maintain a maternofetal-risk-free pregnancy till term and give birth to healthy children without sickle cell disease. Knowing that unplanned pregnancies are more likely to increase maternofetal morbidity and mortality, we sought out to explore the pregnancy preferences in female patients with sickle cell disease to promote healthy conception and childbirth in this vulnerable population. &lt;b&gt;Methodology:&lt;/b&gt; We conducted a cross-sectional study involving female patients of child-bearing age with sickle cell disease followed at Laquintinie Hospital Douala or who were members of a local sickle cell association. Pregnancy preferences were determined using the Desire to Avoid Pregnancy (DAP) scale. Factors associated with pregnancy preferences were determined using multivariable linear regression model. Threshold for significance was set at p &lt; 0.05. &lt;b&gt;Results:&lt;/b&gt; Seventy-seven patients were included with a mean age of 24.71 &amp;#177; 5.53 years. Forty patients (51.95%) had one sexual partner and thirteen women (32.5%) used contraceptive methods. Most patients (46.0%) responded &amp;#8220;Strongly Agree&amp;#8221; or &amp;#8220;Agree&amp;#8221; to the statement &amp;#8220;it would be a good thing for me if I became pregnant in the next 3 months&amp;#8221;. The mean DAP score was 1.63 &amp;#177; 0.91 [1.28 &amp;#177; 0.82 in those who had a sexual partner and 1.99 &amp;#177; 0.86 in those who had no sexual partner]. Factors that were positively associated with DAP score were students (b = 0.32, 95% CI [0.21, 0.95], p = 0.003), monthly income &amp;#8805; 100,000 FCFA (b = 0.24, 95% CI [0.07, 0.81], p = 0.022), and not having a sexual partner (b = 0.26, 95% CI [0.11, 0.85], p = 0.012). &lt;b&gt;Conclusion:&lt;/b&gt; Most female patients with SCD have a low desire to avoid pregnancy. This is especially true for patients who are not students, have a partner and have a low monthly income.
 
</p></abstract><kwd-group><kwd>Pregnancy Preferences</kwd><kwd> Sickle Cell Disease</kwd><kwd> Laquintinie Hospital</kwd><kwd> Cameroun</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Sickle cell disease is a hereditary disease linked to a qualitative abnormality of hemoglobin making individuals affected more prone to hemolysis and vasoocclusive phenomena. It affects approximately 30 million people worldwide and involves 300,000 births each year [<xref ref-type="bibr" rid="scirp.133294-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.133294-ref2">2</xref>] . It affects approximately 0.49, 0.07, 0.68, and 10.68 per thousand live births in America, Europe, Asia, an Africa respectively [<xref ref-type="bibr" rid="scirp.133294-ref3">3</xref>] . Reports suggest that 25% - 30% of Cameroonians are carriers of the sickle cell trait in its heterozygous form, while 2% - 3% of them possess the homozygous form [<xref ref-type="bibr" rid="scirp.133294-ref4">4</xref>] .</p><p>Sickle cell disease represents a public health problem because it is linked to high morbidity and mortality [<xref ref-type="bibr" rid="scirp.133294-ref5">5</xref>] . Before the 1970s, very few children with sickle cell disease survived beyond the age of 10 years [<xref ref-type="bibr" rid="scirp.133294-ref6">6</xref>] . With the implementation of neonatal screening, prevention and treatment of acute complications, particularly infections, survival has improved over the years [<xref ref-type="bibr" rid="scirp.133294-ref7">7</xref>] . Life expectancy increased from 14 years in 1973 to 50 years in 2003 [<xref ref-type="bibr" rid="scirp.133294-ref8">8</xref>] . As a result, questions relating to reproduction have taken on an increasingly important role in the care of female patients with sickle cell disease [<xref ref-type="bibr" rid="scirp.133294-ref9">9</xref>] .</p><p>Reproduction is an important aspect of a woman’s life, and this is especially true for African women [<xref ref-type="bibr" rid="scirp.133294-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.133294-ref11">11</xref>] . According to the WHO an adequate female reproductive life implies that a woman has a satisfactory sex life and has the capacity and the freedom to have children or not. Puberty brings about all morphological modifications necessary for the acquisition of the reproductive function [<xref ref-type="bibr" rid="scirp.133294-ref12">12</xref>] . In women with sickle cell disease, pubertal development is delayed. Menarche has been reported to be retarded by up to 2.4 years in female patients with sickle cell disease [<xref ref-type="bibr" rid="scirp.133294-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.133294-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.133294-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.133294-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.133294-ref17">17</xref>] . Females with sickle cell disease are subject to many worries, doubts and questions relating to their abilities to conceive, their capacity to maintain a maternofetal-risk-free pregnancy till term and give birth to healthy children without sickle cell disease. Though pregnancy in patients with sickle cell disease is associated with a risk of mortality [<xref ref-type="bibr" rid="scirp.133294-ref18">18</xref>] , there is a wide variation in maternal mortality ranging from 0.07% in the United States [<xref ref-type="bibr" rid="scirp.133294-ref19">19</xref>] to more than 9.2% in Nigeria [<xref ref-type="bibr" rid="scirp.133294-ref20">20</xref>] and many pregnancies have reported a favorable outcome [<xref ref-type="bibr" rid="scirp.133294-ref21">21</xref>] . Pregnancies that are unplanned are more likely to result in low birth weight, preterm births, disease transmission and maternofetal deaths [<xref ref-type="bibr" rid="scirp.133294-ref22">22</xref>] . There is currently a lack of prior research on specific aspects of pregnancy preferences (e.g., desired timing) in SCD population globally and validated tools like the Desire to Avoid Pregnancy (DAP), seldom used in resource-limited settings, constitute promising tools to evaluate these preferences. We therefore sought to explore the pregnancy preferences in female patients with sickle cell disease at Laquintinie, Cameroon.</p></sec><sec id="s2"><title>2. Methodology</title><p>Study Design and study setting: This was a cross-sectional study carried out at Laquintinie Hospital Douala (LHD). LHD is a second-category reference hospital built in 1931 in Douala, the economic capital of Cameroon. More specifically, the study was conducted at the integrated sickle cell treatment center, also known as the Emmanuel Bilong Centre (EBC), which operates under the paediatrics department. It is the sole centre in Cameroon exclusively devoted to the care of patients with sickle cell disease. Around 350 patients are seen monthly for routine, acute and chronic complications. Patients were also recruited from a local sickle cell association named Warriors against Sickle Cell Disease (WAS). This association is located in Douala and has more than 150 active members with sickle cell disease.</p><p>Study period: The study was carried out over a period of 8 months from November 2022 to June 2023.</p><p>Population selection: Eligible patients were all female patients with sickle cell disease of child-bearing age consulted at LHD or belonging to the WAS association. In this particular context, convenient and snow-ball sampling techniques were implemented due to the expected social stigma linked to sickle cell disease and engaging in conversations with researchers about pregnancy preferences, both of which have the potential to induce psychological distress and reduce research uptake. We included only patients aged 15 - 45 years. Patients or caregivers of patients between 15 - 17 years who did not provide informed consent to participate in the study were excluded.</p><p>Outcome of interest: The main outcome of interest was the mean Desire to Avoid Pregnancy (DAP) score. We compared the mean DAP score in female patients with sickle cell disease who had a main sexual partner and those who had no sexual partner.</p><p>Sample size calculation: Goleen et al. in the US in 2019 [<xref ref-type="bibr" rid="scirp.133294-ref23">23</xref>] reported that female patients with no sexual partner have a mean DAP score of 2.54 &#177; 0.93 in patients while those with a sexual partner had a mean DAP score of 1.86 &#177; 1.03. Based on these results, for a desired confidence interval of 95%, a power of 80%, the ratio of exposed samples to those not exposed to 1, a significance threshold of 5%, the minimum sample size is 33 patients in each exposure group, giving a total of 66 patients [<xref ref-type="bibr" rid="scirp.133294-ref24">24</xref>] .</p><p>Data collection tools and procedures: Patients meeting the eligibility criteria were identified in the outpatient clinic of the EBC and at the WAS association. Eligible patients received an information leaflet. The women who agreed to participate in the study could provide their informed consent immediately or at any other convenient time for them. For those wishing to defer their consent, their telephone numbers were registered, and we contacted them at a time convenient for them to enquire about their consent status. After obtaining consent, a questionnaire was administered to the patients to gather sociodemographic and clinical information such as the profession, educational level, partner status, frequency of vaso-occlusive crises and transfusions and a brief gynaecological and obstetrical history including use of contraceptives, age at menarche, menstrual characteristics, and previous pregnancies.</p><p>The Desire to Avoid Pregnancy (DAP) scale: The DAP scale has been reported to be a valid and reliable measure of women’s desire to avoid pregnancy and is highly predictive of pregnancy within the next 12 months with eighty per cent of women with the lowest DAP score reported to get pregnant within 12 months, compared with &lt; 1% of those with the highest DAP score [<xref ref-type="bibr" rid="scirp.133294-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.133294-ref26">26</xref>] . The DAP (Desire to Avoid Pregnancy) score was developed and evaluated in the United States in 2019 by Rocca et al., validated by various studies including that of Jessica Gipson et al. in the United States of America in 2021 [<xref ref-type="bibr" rid="scirp.133294-ref27">27</xref>] which assessed the desire to avoid pregnancy and the use of contraceptives among women treated with methadone in Los Angeles (α = 0.92) and that of Jennifer Hall et al in 2022 [<xref ref-type="bibr" rid="scirp.133294-ref26">26</xref>] which evaluated the desire to avoid pregnancy score in the United Kingdom (α = 0.96). It is a psychometrically validated measure assessing women's preferences regarding pregnancy and childbearing prospectively, comprising three domains: 1) cognitive preferences, 2) affective feelings and attitudes towards pregnancy, 3) the anticipated practical consequences in the event of pregnancy. It consists of 14 items, each of which uses a five-point Likert scale rated from 0 - 4 asking women to what extent they agree or disagree with a statement concerning becoming pregnant in the next 3 months or have a baby in the coming year. For negatively worded items, 4 corresponds to “strongly agree”; for positively worded items, 4 corresponds to “strongly disagree”.</p><p>The average of the responses is calculated giving a total score varying between 0 - 4. Higher scores reflect a greater desire to avoid pregnancy. The DAP score is intended to be used as a continuous measure and rounding scores is not recommended. The particularities of this score are diverse: it is the only score evaluating women’s preferences for pregnancy prospectively. It does not only allow the expression of a positive or negative feeling but also ambiguity and uncertainty, it was designed for prospective use, in other words to identify women who wish to have or not have a pregnancy in the near future. No studies using the DAP score were found in Africa.</p><p>The total DAP score in our study had a Cronbach’s Alpha is 0.92 which denotes excellent reliability, indicating that the items measure the underlying construct very consistently.</p><p>Statistical analysis: Data was entered and analysed using the SPSS version 23 software. Quantitative variables were presented as mean and standard deviations, while qualitative variables were presented as frequencies (counts) and percentages. Mean values were compared between patients with a sexual partner and those without a sexual partner using the independent Student t-test. Multivariable linear regression analysis was then performed using clinically relevant variables like contraceptive use, socioeconomic status, nulliparity etc. that were statistically significant on univariate analysis to identify independent factors associated with DAP score. Statistical significance was set at p &lt; 0.05 and the strength of the association was expressed as odds ratio with the 95% Confidence Interval (CI).</p><p>To assess the reliability of our score we used the Cronbach α coefficient. For the interpretation of Cronbach’s alpha, values &gt; 0.9 reflected excellent reliability; &gt;0.8 reflected good reliability, &gt;0.7 reflected acceptable reliability, &gt;0.6 reflected questionable reliability, &gt;0.5 reflected weak reliability, &lt; 0.5 reflected reliability that was not acceptable.</p><p>Ethical considerations: Ethical clearance was obtained from the Institutional Ethics Committee for Research on Human Health of the University of Douala No 3578 CEI-UDo/03/2023/T. Eligible patients were clearly informed of the purpose of the study and their consent was obtained prior to inclusion in the study. Our study was carried out in strict compliance with the fundamental principles of medical research.</p><p>Operational definitions</p><p>&#183; Childbearing age: this is the period during which the woman is physiologically fertile; according to the WHO it is between 15 and 45 years old [<xref ref-type="bibr" rid="scirp.133294-ref23">23</xref>] .</p><p>&#183; Quantity of menstrual flow: This is the volume of blood lost during periods. It was estimated indirectly using the number of sanitary pads/tampons used per day. It was considered normal if &lt; 5 tampons/pads were used per day</p><p>&#183; Sexual partner: Person with whom the patient has a romantic relationship and is considered as most serious to her.</p></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Patient Recruitment</title><p>Of the 136 eligible participants, 43.38% (n = 59) were excluded for various reasons which included refusal to participate (n = 25), unreachable on phone (n = 21), absent contact information (n = 5), and living out of Douala (n = 8).</p></sec><sec id="s3_2"><title>3.2. Sociodemographic Characteristics of Patients</title><p>Ages ranged from 15 - 41 years with a mean age of 24.71 &#177; 5.53 years. The most represented age group were the patients aged 20 - 29 years old (n = 48, 62.3%). Most patients were students (n = 36, 46.8%), single (n = 70, 90.9%), had attained tertiary level education (n = 38, 49.3%) and had a monthly income below 100,000 FCFA (n = 53, 68.9%).</p></sec><sec id="s3_3"><title>3.3. Clinical Characteristics of Sickle Cell Disease</title><p>In the 12 months prior to inclusion, most patients reported less than 10 vaso-occlusive crises (n = 51, 66.2%), one to two hospitalisations (n = 51, 66.2%) and to have no transfusion (n = 49, n = 63.6%). Most used routine medication was folic acid (n = 66, 85.7%). Three in 10 patients had abnormal body mass index: 19.7% (n = 13) underweight and 7.58% overweight (n = 5).</p></sec><sec id="s3_4"><title>3.4. Menstrual Characteristics and Sexual Life</title><p>Mean age of menarche was 15.18 &#177; 2.56 years with a range of 11 - 24 years. Late menarche was reported in 20.8% of patients (n = 16). Mean age of first sexual intercourse was 20.15 &#177; 2.57 years and most patients had their first sexual intercourse after 18 years (n = 41, 77.36%). Most patients (n = 71, 92.2%) had a normal menstrual cycle length. The mean cycle duration was 28.6 &#177; 4.56 days. Both duration (2-7 days) and quantity of menstrual flow (&lt;5 pads/tampons per day) was considered normal in all our patients. The number of cumulative sexual partners varied between 1 and 7 with an average of 3.02 partners since first sexual intercourse. A total of 51.95% (n = 40) of patients had one sexual partner: 42.86% (n = 33) lived separately from their partner and 9.09% (n = 7) lived with their partner. Thirteen women (32.5%) used contraceptive methods: condoms (n = 11, 27.5%), oral contraceptive pills (n = 1, 2.5%) and injectable contraceptives (n = 1, 2.5%). Of those with partners, only 40% (n = 16) knew the haemoglobin electrophoresis status of their partners and this was HbAA (n = 15) in most.</p></sec><sec id="s3_5"><title>3.5. Desire to Avoid Pregnancy (DAP)</title><p>Most patients (46.0%) responded “Strongly Agree” and “Agree” to Item1 statement “it would be a good thing for me if I became pregnant in the next 3 months” which represents evaluation of cognitive desires and preferences. Similarly, most patients (40.5%) responded agreed to Item 10 statement “Thinking about having a baby within the next year makes me smile” which represents affective feelings and attitudes. For the evaluation of anticipated practical consequences, most patients (25.7%) responded “strongly disagree” to the Item 13 statement “If I had a baby in the next year, it would be hard for me to manage raising the child” as shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p><p>Though the Cronbach’s alpha coefficient for the overall DAP scale in our sample was 0.81, the Items 5 and 11 had unacceptable reliable scores as shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</p><p>The mean DAP score was 1.63 &#177; 0.91 with ranges from 0.14 to 3.29. Patients who had a sexual partner had a mean DAP score of 1.28 &#177; 0.82 while patients who had no sexual partner had a mean DAP score of 1.99 &#177; 0.86. The only variable</p><p>that influenced DAP score based on partner status was the age group 20-29 years. Patients with no sexual partner in this age group has a higher mean DAP score compared to patients without a sexual partner as shown in <xref ref-type="table" rid="table1">Table 1</xref>.</p></sec><sec id="s3_6"><title>3.6. Factors Associated with Desire to Avoid Pregnancy (DAP)</title><p>Factors that were positively associated with DAP score were being a student (b = 0.32, 95% CI [0.21, 0.95], p = 0.003), monthly income ≥ 100,000 FCFA (b = 0.24, 95% CI [0.07, 0.81], p = 0.022), and no sexual partner (b = 0.26, 95% CI [0.11, 0.85], p = 0.012) as shown in <xref ref-type="table" rid="table2">Table 2</xref>.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Comparing the DAP score and selected variables in patients based on partner status</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Variables</th><th align="center" valign="middle"  colspan="2"  >DAP Score &#177; Standard Deviation (SD)</th><th align="center" valign="middle"  rowspan="2"  >p-value</th></tr></thead><tr><td align="center" valign="middle" >SP1 (n = 40)</td><td align="center" valign="middle" >SP0 (n = 37)</td></tr><tr><td align="center" valign="middle" >Attained tertiary education (n = 38)</td><td align="center" valign="middle" >1.22 &#177; 0.78</td><td align="center" valign="middle" >1.93 &#177; 0.71</td><td align="center" valign="middle" >1.000</td></tr><tr><td align="center" valign="middle" >Single marital status (n = 70)*</td><td align="center" valign="middle" >1.25 &#177; 0.76</td><td align="center" valign="middle" >1.99 &#177; 0.86</td><td align="center" valign="middle" >--</td></tr><tr><td align="center" valign="middle" >Pregnant before (n = 26)</td><td align="center" valign="middle" >1.45 &#177; 0.91</td><td align="center" valign="middle" >1.48 &#177; 0.77</td><td align="center" valign="middle" >1.000</td></tr><tr><td align="center" valign="middle" >Student (n = 36)</td><td align="center" valign="middle" >1.51 &#177; 0.74</td><td align="center" valign="middle" >2.37 &#177; 0.58</td><td align="center" valign="middle" >1.000</td></tr><tr><td align="center" valign="middle" >Monthly income ≥ 100,000 FCFA (n = 43)</td><td align="center" valign="middle" >1.46 &#177; 0.83</td><td align="center" valign="middle" >2.24 &#177; 0.83</td><td align="center" valign="middle" >1.000</td></tr><tr><td align="center" valign="middle" >Aged 20 - 29 years (n = 48)</td><td align="center" valign="middle" >1.44 &#177; 0.91</td><td align="center" valign="middle" >1.86 &#177; 0.86</td><td align="center" valign="middle" >0.048</td></tr><tr><td align="center" valign="middle" >Less than 10 VOCs/year (n = )</td><td align="center" valign="middle" >1.35 &#177; 0.86</td><td align="center" valign="middle" >1.91 &#177; 0.90</td><td align="center" valign="middle" >0.085</td></tr><tr><td align="center" valign="middle" >≥1 transfusion (s)/year (n = 28)</td><td align="center" valign="middle" >1.37 &#177; 0.99</td><td align="center" valign="middle" >2.04 &#177; 0.84</td><td align="center" valign="middle" >0.532</td></tr><tr><td align="center" valign="middle" >≥1 hospitalisations/year (n = 55)</td><td align="center" valign="middle" >1.17 &#177; 0.87</td><td align="center" valign="middle" >2.02 &#177; 0.94</td><td align="center" valign="middle" >0.313</td></tr><tr><td align="center" valign="middle" >Late menarche (n = 16)</td><td align="center" valign="middle" >0.97 &#177; 0.56</td><td align="center" valign="middle" >1.75 &#177; 0.98</td><td align="center" valign="middle" >0.862</td></tr><tr><td align="center" valign="middle" >Abnormal menstrual cycle (n = 6)</td><td align="center" valign="middle" >0.69 &#177; 0.27</td><td align="center" valign="middle" >2.36 &#177; 0.30</td><td align="center" valign="middle" >0.240</td></tr></tbody></table></table-wrap><p>REF = Reference group which represent categories that are opposite to the stated risk groups (more likely to have a low desire to avoid pregnancy). DAP = Desire to avoid pregnancy scale. SD = Standard deviation. SP1 = Patients that have a sexual partner. SP0 = Patients that do not have a sexual partner. Bold values represent variable with p &lt; 0.05 (significance). *Insufficient data to run a regression analysis.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Comparing the DAP score and selected variables in patients based on risk groups</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Variables</th><th align="center" valign="middle"  rowspan="2"  >DAP score in Risk group</th><th align="center" valign="middle"  rowspan="2"  >DAP score in REF group &#177; SD</th><th align="center" valign="middle"  colspan="2"  >Univariate analysis</th><th align="center" valign="middle"  colspan="2"  >Multivariable analysis</th></tr></thead><tr><td align="center" valign="middle" >b [95% CI]</td><td align="center" valign="middle" >p-value</td><td align="center" valign="middle" >b [95% CI]</td><td align="center" valign="middle" >p-value</td></tr><tr><td align="center" valign="middle" >Attained tertiary education (n = 38)</td><td align="center" valign="middle" >1.48 &#177; 0.82</td><td align="center" valign="middle" >1.79 &#177; 0.96</td><td align="center" valign="middle" >−0.17 [−0.72, 0.11]</td><td align="center" valign="middle" >0.150</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Single marital status (n = 70)</td><td align="center" valign="middle" >1.64 &#177; 0.89</td><td align="center" valign="middle" >1.46 &#177; 1.25</td><td align="center" valign="middle" >0.05 [−0.66, 1.03]</td><td align="center" valign="middle" >0.658</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Pregnant before (n = 26)</td><td align="center" valign="middle" >1.46 &#177; 0.85</td><td align="center" valign="middle" >1.15 &#177; 0.77</td><td align="center" valign="middle" >−0.13 [−0.71, 0.2]</td><td align="center" valign="middle" >0.266</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Contraceptive use (n = 13)*</td><td align="center" valign="middle" >1.63 &#177; 0.76</td><td align="center" valign="middle" >1.13 &#177; 0.86</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Student (n = 36)</td><td align="center" valign="middle" >2.05 &#177; 0.84</td><td align="center" valign="middle" >1.26 &#177; 0.81</td><td align="center" valign="middle" >0.44 [0.41, 1.18]</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >0.32 [0.21, 0.95]</td><td align="center" valign="middle" >0.003</td></tr><tr><td align="center" valign="middle" >Monthly income ≥ 100,000 FCFA (n = 43)</td><td align="center" valign="middle" >1.92 &#177; 0.91</td><td align="center" valign="middle" >1.25 &#177; 0.78</td><td align="center" valign="middle" >0.37 [0.27−1.07]</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.24[0.07, 0.81]</td><td align="center" valign="middle" >0.022</td></tr><tr><td align="center" valign="middle" >Aged 20 - 29 years (n = 48)</td><td align="center" valign="middle" >1.64 &#177; 0.90</td><td align="center" valign="middle" >1.61 &#177; 0.95</td><td align="center" valign="middle" >0.02 [−0.41, 0.47]</td><td align="center" valign="middle" >0.898</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Less than 10 VOCs/year (n = 62)</td><td align="center" valign="middle" >1.64 &#177; 0.92</td><td align="center" valign="middle" >1.61 &#177; 0.90</td><td align="center" valign="middle" >0.01 [−0.53, 0.58]</td><td align="center" valign="middle" >0.927</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >≥1 transfusion (s)/year (n = 28)</td><td align="center" valign="middle" >1.66 &#177; 0.97</td><td align="center" valign="middle" >1.61 &#177; 0.88</td><td align="center" valign="middle" >0.21 [0.39, 0.48]</td><td align="center" valign="middle" >0.838</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >≥1 hospitalisations/year (n = 55)</td><td align="center" valign="middle" >1.65 &#177; 0.99</td><td align="center" valign="middle" >1.58 &#177; 0.67</td><td align="center" valign="middle" >0.04 [0.39, 0.55]</td><td align="center" valign="middle" >0.739</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Late menarche (n = 16)</td><td align="center" valign="middle" >1.36 &#177; 0.87</td><td align="center" valign="middle" >1.71 &#177; 0.91</td><td align="center" valign="middle" >−0.16 [−0.85. −0.17]</td><td align="center" valign="middle" >0.183</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Abnormal menstrual cycle (n = 6)</td><td align="center" valign="middle" >1.36 &#177; 0.94</td><td align="center" valign="middle" >1.65 &#177; 0.91</td><td align="center" valign="middle" >−0.08 [−1.14, −0.55]</td><td align="center" valign="middle" >0.487</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >No sexual partner (n = 37)</td><td align="center" valign="middle" >1.99 &#177; 0.86</td><td align="center" valign="middle" >1.28 &#177; 0.82</td><td align="center" valign="middle" >0.39 [0.32, 1.1]</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.26 [0.11, 0.85]</td><td align="center" valign="middle" >0.012</td></tr></tbody></table></table-wrap><p>DAP = Desire to avoid pregnancy scale. SD = Standard deviation. b = Standardised coefficient of regression. Bold values represent variable with p &lt; 0.05 (significance). CI = Confidence interval. *Insufficient data to run a regression analysis.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>Given that unplanned pregnancies are more likely to result in adverse maternofetal outcomes, we sought to investigate pregnancy preferences in female patients with sickle cell disease to promote healthy conception and childbirth in this vulnerable population. From this study, we note that most female patients with SCD have a low desire to avoid pregnancy. Nonetheless, being a student, having a monthly income ≥ 100,000 FCFA and not having a sexual partner were associated with higher desires to avoid pregnancy.</p><p>Even though several students have unprotected sex with opposite-sex partners, they tend to have a strong intention to avoid pregnancy. Aside from the obvious low financial power associated with being a student, this finding may be explained by the fact that pregnancy could make it significantly more difficult for students to finish their degrees within specific time intervals [<xref ref-type="bibr" rid="scirp.133294-ref28">28</xref>] . Other professions are usually associated with older age and better economic power. These women are assumed to have more time to plan for their pregnancy, carry-on pregnancies till term and take adequate care of their children. Therefore, it would be expected that non-students have a lower desire to avoid pregnancy as shown in our study.</p><p>It could be believed that women with higher economic power can overcome more financial challenges associated with high-risk pregnancies and therefore may be more willing than others to desire and plan pregnancies. In our study, however, women who had relatively higher economic power also had higher desires to avoid pregnancy as reported by some authors [<xref ref-type="bibr" rid="scirp.133294-ref29">29</xref>] . This finding may be explained by contraceptive use. Many studies in the developing world have reported that wealthier women are more likely than their less wealthy counterparts to use family planning methods and maternal health care services [<xref ref-type="bibr" rid="scirp.133294-ref30">30</xref>] [<xref ref-type="bibr" rid="scirp.133294-ref31">31</xref>] [<xref ref-type="bibr" rid="scirp.133294-ref32">32</xref>] . In our study, though not statistically significant, patients who reported contraceptive use had a higher DAP score compared to patients that did not report contraceptive use (1.63 &#177; 0.76 vs 1.13 &#177; 0.86) as similarly reported by other authors [<xref ref-type="bibr" rid="scirp.133294-ref23">23</xref>] . Therefore, it is plausible that contraceptive use constituted a significant confounding variable in our study.</p><p>From our study, partner status had the greatest influence on mean DAP score (b = 0.26). Patients who had a sexual partner had a mean DAP score of 1.28 &#177; 0.82 while patients who had no sexual partner had a mean DAP score of 1.99 &#177; 0.86. This translates into the fact that people who had no partner had a higher desire to avoid pregnancy. A partner can significantly influence a woman’s pregnancy preferences. In a US study, women without sickle cell disease who did not have a partner had a DAP score of 2.54 &#177; 0.93 (vs 1.86 &#177; 1.03) [<xref ref-type="bibr" rid="scirp.133294-ref23">23</xref>] , which is much higher than DAP score in patients with SCD without a partner (1.99 &#177; 0.86). The lower desire to avoid pregnancy in patients with SCD compared to the overall population is multifaceted and may be influenced by the woman’s knowledge or perception of her partner’s reproductive wishes and by the lack of a suitable life partner who is compatible, accepts her illness and is supportive [<xref ref-type="bibr" rid="scirp.133294-ref33">33</xref>] . Whenever a suitable life partner sets in, the fear of not getting a better alternative may influence their pregnancy preferences at any given time.</p><p>The mean DAP score in our sample was 1.63 &#177; 0.91. This value is at the lower end of the DAP score and implies that most female patients with sickle cell disease had a low desire to avoid pregnancy. This contrasts with the mean DAP score (2.53 &#177; 1.05) obtained in UK women without sickle cell disease. In 2021, fertility rate in Cameroon was 4.5 births per woman, 0.8 in China, 1.4 in Greece, 1.6 in Germany, 1.7 in USA and 1.8 in France [<xref ref-type="bibr" rid="scirp.133294-ref34">34</xref>] . Though this high birth rate has been attributed to unintended pregnancies, the lower DAP score in our study may imply that a good proportion of these pregnancies in Cameroon may be intended. Reports suggest that Black women are less inclined to decline sex with a partner, have a negative attitude about contraception, are more likely to anticipate having sex without contraception than white women and anticipate more favourable outcomes if they get pregnant at a certain point in their life [<xref ref-type="bibr" rid="scirp.133294-ref35">35</xref>] . The DAP scale has not been studied extensively in African setting and therefore comparing our values with context-specific studies is quite difficult. Nonetheless, our finding correlates with trends described in African settings before [<xref ref-type="bibr" rid="scirp.133294-ref36">36</xref>] [<xref ref-type="bibr" rid="scirp.133294-ref37">37</xref>] with 59.8% of Cameroonian women of reproductive age preferring to space rather than limit pregnancies [<xref ref-type="bibr" rid="scirp.133294-ref37">37</xref>] .</p><p>The non-probabilistic sampling methods used in this study, the unacceptable reliability of some individual score items (e.g. 5 and 11), the cross-sectional nature of the study constitutes significant limitations to the study’s generalizability. Nonetheless, our study is the first to evaluate pregnancy preferences in sickle cell population using a validated tool in Africa.</p><p>More studies evaluating pregnancy preferences (using the DAP score or other tools like the One Key Question&#210; tool [<xref ref-type="bibr" rid="scirp.133294-ref38">38</xref>] ) to predict onset of pregnancy in the near future and exploring maternofetal outcomes of pregnancies in females with sickle cell disease need to be conducted. Conception is central for every culture, especially African culture, and therefore, efforts to tailor conception care to individual patient’s needs, including for female patients with SCD, should be promoted.</p></sec><sec id="s5"><title>5. Conclusions</title><p>In summary, the mean DAP score for female patients with SCD was low, denoting a low desire to avoid pregnancy. Being a student, having a monthly income ≥100000FCFA and not having a sexual partner were associated with higher desires to avoid pregnancy. The DAP score is a promising tool to evaluate pregnancy preferences in Cameroon.</p><p>What is known about the topic?</p><p>&#183; Females with sickle cell disease (SCD), despite having a delayed pubertal development, are subject to many worries relating to their abilities to conceive, their capacity to maintain a materno-foetal-risk-free pregnancy till term and give birth to healthy children without sickle cell disease.</p><p>&#183; There is a lack of prior research on specific aspects of pregnancy preferences (e.g., desired timing) in SCD population globally.</p><p>&#183; The Desire to Avoid Pregnancy (DAP) is a promising tool to evaluate these preferences and has seldom been used in resource-limited settings.</p><p>What this study adds?</p><p>&#183; Most female patients with SCD have a low desire to avoid pregnancy. Most patients (46.0%) responded “Strongly Agree” or “Agree” to the statement “it would be a good thing for me if I became pregnant in the next 3 months.</p><p>&#183; Being a student, having a monthly income ≥100000FCFA and not having a sexual partner were associated with higher desires to avoid pregnancy.</p><p>&#183; The total DAP score has good reliability (0.92) and therefore is a promising tool to evaluate pregnancy preferences in Cameroonian women with sickle cell disease.</p></sec><sec id="s6"><title>Data Availability Statement</title><p>The data that support the findings of this study are available on request from the corresponding author, CEE.</p></sec><sec id="s7"><title>Acknowledgements</title><p>We thank the administration of the hospital, the personnel at the paediatric department, and the Kangaroo Mother Care team for easing data collection procedures.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s9"><title>Cite this paper</title><p>Charlotte, E.E., Massako, J.D., Nkwele, M.F., Edgar, M.M.L., Yolande, P.D., Bounyom, M.B., Njiengwe, E.F., Patricia, &#201;., Iyawa, H., Bitsie, D.M., Nsang, E.H., Abba, S., Eleonore, N.L.E., Astrid, N.K., Toutou, G.T., Bilkissou, M. and Henri, E. (2024) Pregnancy Preferences in Females of Reproductive Age with Sickle Cell Disease at Laquintinie Hospital: A Cross-Sectional Analysis. Open Journal of Obstetrics and Gynecology, 14, 744-757. https://doi.org/10.4236/ojog.2024.145062</p></sec></body><back><ref-list><title>References</title><ref id="scirp.133294-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Dapa, D. and Gil, T. (2002) Sickle Cell Disease in Africa. &lt;i&gt;Current Opinion in H&lt;/i&gt;&lt;i&gt;e&lt;/i&gt;&lt;i&gt;matology&lt;/i&gt;, 9, 111-116. &lt;br&gt;https://pubmed.ncbi.nlm.nih.gov/11844993/ </mixed-citation></ref><ref id="scirp.133294-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Angastiniotis, M., Modell, B., Englezos, P. and Boulyjenkov, V. (1995) Prevention and Control of Haemoglobinopathies. &lt;i&gt;Bulletin of the World Health Organization&lt;/i&gt;, 73, 375-386.</mixed-citation></ref><ref id="scirp.133294-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Asnani, M.R., Quimby, K.R., Bennett, N.R. and Francis, D.K. (2016) Interventions for Patients and Caregivers to Improve Knowledge of Sickle Cell Disease and Recognition of Its Related Complications. &lt;i&gt;Database of Systematic Reviews&lt;/i&gt;, 10, CD011175. &lt;br&gt;https://doi.org/10.1002/14651858.CD011175.pub2</mixed-citation></ref><ref id="scirp.133294-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Chetcha Chemegni, B., Ola&amp;#8217;a Mbamzock, E., Ngo Sack, F., Ngouadjeu, E. and Mbanya, D. (2018) Morbidit&amp;#233; et Mortalit&amp;#233; chez les Patients Dr&amp;#233;panocytaires au Service d&amp;#8217;H&amp;#233;matologie de l&amp;#8217;H&amp;#244;pital Central de Yaound&amp;#233;. &lt;i&gt;Health Sciences and Disease&lt;/i&gt;, 19, 71-75.</mixed-citation></ref><ref id="scirp.133294-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Stuart, M.J. and Nagel, R.L. (2004) Sickle-Cell Disease. &lt;i&gt;The Lancet&lt;/i&gt;, 364, 1343-1360. &lt;br&gt;https://linkinghub.elsevier.com/retrieve/pii/S0140673604171924 </mixed-citation></ref><ref id="scirp.133294-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Chakravorty, S. and Williams, T.N. (2015) Sickle Cell Disease: A Neglected Chronic Disease of Increasing Global Health Importance. &lt;i&gt;Archives of Disease in Childhood&lt;/i&gt;, 100, 48-53. &lt;br&gt;https://doi.org/10.1136/archdischild-2013-303773</mixed-citation></ref><ref id="scirp.133294-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">De Montelembert, M. and Tsilolo, L. (2007) Les progr&amp;#232;s th&amp;#233;rapeutiques dans la prise en charge de la dr&amp;#233;panocytose sont ils applicables en Afrique subsaha. &lt;br&gt;https://www.jle.com/en/MedSanteTrop/2007/67.6/612-616 Les progrès thérapeutiques dans la prise en charge de la drépanocytose sont ils applicables en Afrique subsaha.pdf </mixed-citation></ref><ref id="scirp.133294-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Claster, S. and Vichinsky, E.P. (2003) Managing Sickle Cell Disease. &lt;i&gt;BMJ&lt;/i&gt;, 327, 1151-1155. &lt;br&gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC261819/ </mixed-citation></ref><ref id="scirp.133294-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Smith-Whitley, K. (2014) Reproductive Issues in Sickle Cell Disease. &lt;i&gt;Hematology&lt;/i&gt;,&lt;i&gt; ASH Education Program&lt;/i&gt;, 124, 418-424. &lt;br&gt;https://doi.org/10.1182/asheducation-2014.1.418</mixed-citation></ref><ref id="scirp.133294-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Donkor, E.S. and Sandall, J. (2009) Coping Strategies of Women Seeking Infertility Treatment in Southern Ghana. &lt;i&gt;African Journal of Reproductive Health&lt;/i&gt;, 13, 81-94. &lt;br&gt;https://www.ajol.info/index.php/ajrh/article/view/55736 </mixed-citation></ref><ref id="scirp.133294-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Dyer, S.J., Abrahams, N., Mokoena, N.E. and van der Spuy, Z.M. (2004) You Are a Man Because You Have Children: Experiences, Reproductive Health Knowledge and Treatment-Seeking Behaviour among Men Suffering from Couple Infertility in South Africa. &lt;i&gt;Human Reproduction&lt;/i&gt;, 19, 960-967. &lt;br&gt;https://doi.org/10.1093/humrep/deh195</mixed-citation></ref><ref id="scirp.133294-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2023) Reproductive Health. &lt;br&gt;https://www.who.int/southeastasia/health-topics/reproductive-health </mixed-citation></ref><ref id="scirp.133294-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Singhal, A., Thomas, P., Cook, R., Wierenga, K. and Serjeant, G. (1994) Delayed Adolescent Growth in Homozygous Sickle Cell Disease. &lt;i&gt;Archives of Disease in Childhood&lt;/i&gt;, 71, 404-408. &lt;br&gt;https://adc.bmj.com/lookup/doi/10.1136/adc.71.5.404 </mixed-citation></ref><ref id="scirp.133294-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Luban, N., Leikin, S. and August, G. (1982) Growth and Development in Sickle Cell Anemia. Preliminary Report. &lt;i&gt;The American Journal of Pediatric Hematol&lt;/i&gt;&lt;i&gt;o&lt;/i&gt;&lt;i&gt;gy&lt;/i&gt;/&lt;i&gt;Oncology&lt;/i&gt;, 4, 61-65. &lt;br&gt;https://pubmed.ncbi.nlm.nih.gov/7091577/ </mixed-citation></ref><ref id="scirp.133294-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Mohammed-Durosinlorun, A., Bello-Manga, H., Adze, J., Ijei, I.P. and Stephen, B. (2021) Menstrual Characteristics of Sickle Cell Disease Patients Seen at a Tertiary Institution in North Western Nigeria. &lt;i&gt;Annals of African Medicine&lt;/i&gt;, 20, 255-264.</mixed-citation></ref><ref id="scirp.133294-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Zemel, B.S., Kawchak, D.A., Ohene-Frempong, K., Schall, J.I. and Stallings, V.A. (2007) Effects of Delayed Pubertal Development, Nutritional Status, and Disease Severity on Longitudinal Patterns of Growth Failure in Children with Sickle Cell Disease. &lt;i&gt;Pediatric Research&lt;/i&gt;, 61, 607-613. &lt;br&gt;https://www.nature.com/doifinder/10.1203/pdr.0b013e318045bdca </mixed-citation></ref><ref id="scirp.133294-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Serjeant, G.R. (2001) Sickle Cell Disease and Age at Menarche in Jamaican Girls: Observations from a Cohort Study. &lt;i&gt;Archives of Disease in Childhood&lt;/i&gt;, 85, 375-378.&lt;br&gt;https://doi.org/10.1136/adc.85.5.375</mixed-citation></ref><ref id="scirp.133294-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Pauw, S.D., Maccioni, J. and Efira, A. (2014) Patients dr&amp;#233;panocytaires&amp;#8239;: Quel accompagnement m&amp;#233;dical sp&amp;#233;cifique lors de l&amp;#8217;adolescence&amp;#8239;? &lt;i&gt;Revue Medicale de Bruxelles&lt;/i&gt;, 35, 85-95.</mixed-citation></ref><ref id="scirp.133294-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Villers, M., Jamison, M., De Castro, L. and James, A. (2008) Morbidity Associated with Sickle Cell Disease in Pregnancy. &lt;i&gt;American Journal of Obstetrics &amp; Gynecol&lt;/i&gt;&lt;i&gt;o&lt;/i&gt;&lt;i&gt;gy&lt;/i&gt;, 199, 125.E1-125.E5. &lt;br&gt;https://pubmed.ncbi.nlm.nih.gov/18533123/ </mixed-citation></ref><ref id="scirp.133294-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Dare, F.O., Makinde, O.O. and Faasuba, O.B. (1992) The Obstetric Performance of Sickle Cell Disease Patients and Homozygous Hemoglobin C Disease Patients in Ile-Ife, Nigeria. &lt;i&gt;International Journal of Gynecology &amp; Obstetrics&lt;/i&gt;, 37, 163-168. &lt;br&gt;http://doi.wiley.com/10.1016/0020-7292(92)90376-T </mixed-citation></ref><ref id="scirp.133294-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Smith, J., Espeland, M., Bellevue, R., Bonds, D., Brown, A. and Koshy, M. (1996) Pregnancy in Sickle Cell Disease: Experience of the Cooperative Study of Sickle Cell Disease. &lt;i&gt;Obstetrics &amp; Gynecology&lt;/i&gt;, 87, 199-204. &lt;br&gt;http://linkinghub.elsevier.com/retrieve/pii/0029784495003673 </mixed-citation></ref><ref id="scirp.133294-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Montgomery, K.S., Green, T., Maher, B., Tipton, K., O&amp;#8217;Bannon, C., Murphy, T., &lt;i&gt;et al&lt;/i&gt;. (2010) Women&amp;#8217;s Desire for Pregnancy. &lt;i&gt;The Journal of Perinatal Education&lt;/i&gt;, 19, 53-61. &lt;br&gt;https://doi.org/10.1624/105812410X514404</mixed-citation></ref><ref id="scirp.133294-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Samari, G., Foster, D.G., Ralph, L.J. and Rocca, C.H. (2020) Pregnancy Preferences and Contraceptive Use among US Women. &lt;i&gt;Contraception&lt;/i&gt;, 101, 79-85. &lt;br&gt;https://doi.org/10.1016/j.contraception.2019.10.007</mixed-citation></ref><ref id="scirp.133294-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Dean, A.G., Sullivan, K.M. and Soe, M.M. (2013) OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version 3.01. &lt;br&gt;https://www.openepi.com/ </mixed-citation></ref><ref id="scirp.133294-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Hall, J.A., Barrett, G., Stephenson, J.M., Edelman, N.L. and Rocca, C. (2023) Desire to Avoid Pregnancy Scale: Clinical Considerations and Comparison with Other Questions about Pregnancy Preferences. &lt;i&gt;BMJ Sexual &amp; Reproductive Health&lt;/i&gt;, 49, 167-175. &lt;br&gt;https://doi.org/10.1136/bmjsrh-2022-201750</mixed-citation></ref><ref id="scirp.133294-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Hall, J., Barrett, G. and Rocca, C. (2022) Evaluation of the Desire to Avoid Pregnancy Scale in the UK: A Psychometric Analysis Including Predictive Validity. &lt;i&gt;BMJ Open&lt;/i&gt;, 12, e060287. &lt;br&gt;https://doi.org/10.1136/bmjopen-2021-060287</mixed-citation></ref><ref id="scirp.133294-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Gipson, J.D., Bornstein, M., Berger, A. and Rocca, C.H. (2021) Desire to Avoid Pregnancy and Contraceptive Use among Female Methadone Patients in Los Angeles.&lt;i&gt; Contraception&lt;/i&gt;, 103, 322-327. &lt;br&gt;https://doi.org/10.1016/j.contraception.2021.01.019</mixed-citation></ref><ref id="scirp.133294-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Cabral, M.A., Schroeder, R., Armstrong, E.M., El Ayadi, A.M., G&amp;#252;rel, A.L., Chang, J., &lt;i&gt;et al&lt;/i&gt;. (2018) Pregnancy Intentions, Contraceptive Knowledge and Educational Aspirations among Community College Students. &lt;i&gt;Perspectives on Sexual and R&lt;/i&gt;&lt;i&gt;e&lt;/i&gt;&lt;i&gt;productive Health&lt;/i&gt;, 50, 181-188. &lt;br&gt;https://doi.org/10.1363/psrh.12081</mixed-citation></ref><ref id="scirp.133294-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Atake, E.H. and Gnakou Ali, P. (2019) Women&amp;#8217;s Empowerment and fertIlity Preferences in High Fertility Countries in Sub-Saharan Africa. &lt;i&gt;BMC Women&lt;/i&gt;&amp;#8217;&lt;i&gt;s Health&lt;/i&gt;, 19, Article No. 54. &lt;br&gt;https://doi.org/10.1186/s12905-019-0747-9</mixed-citation></ref><ref id="scirp.133294-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Countdown 2008 Equity Analysis Group (2008) Mind the Gap: Equity and Trends in Coverage of Maternal, Newborn, and Child Health Services in 54 Countdown Countries. &lt;i&gt;The Lancet&lt;/i&gt;, 371, 1259-1267. &lt;br&gt;https://doi.org/10.1016/S0140-6736(08)60560-7</mixed-citation></ref><ref id="scirp.133294-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Hosseinpoor, A.R., Victora, C., Bergen, N., Barros, A. and Boerma, T. (2011) Towards Universal Health Coverage: The Role of Within-Country Wealth-Related Inequality in 28 Countries in Sub-Saharan Africa. &lt;i&gt;Bulletin of the World Health O&lt;/i&gt;&lt;i&gt;r&lt;/i&gt;&lt;i&gt;ganization&lt;/i&gt;, 89, 881-890. &lt;br&gt;https://doi.org/10.2471/BLT.11.087536</mixed-citation></ref><ref id="scirp.133294-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Yigzaw, M., Zakus, D., Tadesse, Y., Desalegn, M. and Fantahun, M. (2015) Paving the Way for Universal Family Planning Coverage in Ethiopia: An Analysis of Wealth Related Inequality. &lt;i&gt;International Journal for Equity in Health&lt;/i&gt;, 14, Article No. 77. &lt;br&gt;https://doi.org/10.1186/s12939-015-0214-7</mixed-citation></ref><ref id="scirp.133294-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Zabin, L.S., Huggins, G.R., Emerson, M.R. and Cullins, V.E. (2001) Partner Effects on a Woman&amp;#8217;s Intention to Conceive: &amp;#8220;Not with This Partner&amp;#8221;. &lt;i&gt;Family Planning Perspectives&lt;/i&gt;, 32, 39-45. &lt;br&gt;https://doi.org/10.2307/2648147</mixed-citation></ref><ref id="scirp.133294-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">(2023) World Bank Open Data. &lt;br&gt;https://data.worldbank.org </mixed-citation></ref><ref id="scirp.133294-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Barber, J.S., Yarger, J.E. and Gatny, H.H. (2015) Black-White Differences in Attitudes Related to Pregnancy among Young Women. &lt;i&gt;Demography&lt;/i&gt;, 52, 751-786. &lt;br&gt;https://doi.org/10.1007/s13524-015-0391-4</mixed-citation></ref><ref id="scirp.133294-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Ahinkorah, B.O., Seidu, A.A., Armah-Ansah, E.K., Budu, E., Ameyaw, E.K., Agbaglo, E., &lt;i&gt;et al&lt;/i&gt;. (2020) Drivers of Desire for More Children among Childbearing Women in Sub-Saharan Africa: Implications for Fertility Control. &lt;i&gt;BMC Pregnancy Childbirth&lt;/i&gt;, 20, Article No. 778. &lt;br&gt;https://doi.org/10.1186/s12884-020-03470-1</mixed-citation></ref><ref id="scirp.133294-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Van Lith, L.M., Yahner, M. and Bakamjian, L. (2013) Women&amp;#8217;s Growing Desire to Limit Births in Sub-Saharan Africa: Meeting the Challenge. &lt;i&gt;Global Health&lt;/i&gt;:&lt;i&gt; Science and Practice&lt;/i&gt;, 1, 97-107. &lt;br&gt;https://doi.org/10.9745/GHSP-D-12-00036</mixed-citation></ref><ref id="scirp.133294-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Stulberg, D.B., Datta, A., White Van Gompel, E., Schueler, K. and Rocca, C.H. (2020) One Key Question&amp;#174; and the Desire to Avoid Pregnancy Scale: A comparison of Two Approaches to Asking about Pregnancy Preferences. &lt;i&gt;Contraception&lt;/i&gt;, 101, 231-236. &lt;br&gt;https://doi.org/10.1016/j.contraception.2019.12.010</mixed-citation></ref></ref-list></back></article>